Employee Benefits	9 Months Ended
Sep. 30, 2019
Employee Benefits [Abstract]
Employee Benefits	8. EMPLOYEE BENEFITS ESOP In connection with our conversion and public offering, we established an ESOP. The ESOP borrowed from the Company to purchase 350,000 shares in the offering. The issuance of the shares to the ESOP resulted in a contra account established in the equity section of the balance sheet for the unallocated shares at an amount equal to their $10.00 per share purchase price. The Company may make discretionary contributions to the ESOP and pay dividends on unallocated shares to the ESOP. ICC makes annual contributions to the ESOP sufficient to repay the loan. When loan payments are made, ESOP shares are allocated to participants based on relative compensation and expense is recorded. No contributions to the ESOP were made during the nine months ended September 30, 2019 and 2018, respectively. A compensation expense charge is booked monthly during each year for the shares committed to be allocated to participants that year, determined with reference to the fair market value of our stock at the time the commitment to allocate the shares is accrued and recognized. For the nine months ended September 30, 2019, we recognized compensation expense of $242,788 related to 17,530 shares of our common stock that are committed to be released to participants’ accounts at December 31, 2019. Of the 17,530 shares committed to be released, 1,926 shares were committed on September 30, 2019 and had no impact on the weighted average common shares outstanding for the nine months ended September 30, 2019. For the nine months ended September 30, 2018, we recognized compensation expense of $271,747 related to 17,577 shares of our common stock that were committed to be released to participants’ accounts at December 31, 2018. Of the 17,577 shares committed to be released at December 31, 2018, 1,932 shares were committed on September 30, 2018 and had no impact on the weighted average common shares outstanding for the three and nine months ended September 30, 2018. RESTRICTED STOCK UNITS RSUs were granted for the first time in February 2018 with additional RSUs being granted in March 2019. RSUs have a grant date value equal to the closing price of the Company’s stock on the dates the shares are granted. The RSUs vest 1/3 over three years from the date of grant. As of September 30, 2019, 13,071 and 11,700 RSUs have been granted at a fair market value of $13.70 and $15.10, respectively. We recognized $78,226 and $35,818 of expense on these units in the nine months ended September 30, 2019 and 2018, respectively. Total unrecognized compensation expense relating to outstanding and unvested RSUs was $226,856 as of September 30, 2019, which will be recognized over the remainder of the three-year vesting periods.

8. EMPLOYEE BENEFITS

ESOP

In connection with our conversion and public offering, we established an ESOP. The ESOP borrowed from the Company to purchase 350,000 shares in the offering. The issuance of the shares to the ESOP resulted in a contra account established in the equity section of the balance sheet for the unallocated shares at an amount equal to their $10.00 per share purchase price.

The Company may make discretionary contributions to the ESOP and pay dividends on unallocated shares to the ESOP. ICC makes annual contributions to the ESOP sufficient to repay the loan. When loan payments are made, ESOP shares are allocated to participants based on relative compensation and expense is recorded. No contributions to the ESOP were made during the nine months ended September 30, 2019 and 2018, respectively.

A compensation expense charge is booked monthly during each year for the shares committed to be allocated to participants that year, determined with reference to the fair market value of our stock at the time the commitment to allocate the shares is accrued and recognized. For the nine months ended September 30, 2019, we recognized compensation expense of $242,788 related to 17,530 shares of our common stock that are committed to be released to participants’ accounts at December 31, 2019. Of the 17,530 shares committed to be released, 1,926 shares were committed on September 30, 2019 and had no impact on the weighted average common shares outstanding for the nine months ended September 30, 2019. For the nine months ended September 30, 2018, we recognized compensation expense of $271,747 related to 17,577 shares of our common stock that were committed to be released to participants’ accounts at December 31, 2018. Of the 17,577 shares committed to be released at December 31, 2018, 1,932 shares were committed on September 30, 2018 and had no impact on the weighted average common shares outstanding for the three and nine months ended September 30, 2018.

RESTRICTED STOCK UNITS

RSUs were granted for the first time in February 2018 with additional RSUs being granted in March 2019. RSUs have a grant date value equal to the closing price of the Company’s stock on the dates the shares are granted. The RSUs vest 1/3 over three years from the date of grant.

As of September 30, 2019, 13,071 and 11,700 RSUs have been granted at a fair market value of $13.70 and $15.10, respectively. We recognized $78,226 and $35,818 of expense on these units in the nine months ended September 30, 2019 and 2018, respectively. Total unrecognized compensation expense relating to outstanding and unvested RSUs was $226,856 as of September 30, 2019, which will be recognized over the remainder of the three-year vesting periods.